Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malignancy

Blood (2019) 134 (Supplement_1): 4028.

https://doi.org/10.1182/blood-2019-130223

Published: 2019

Journal Articles

Endogenous Retinoid X Receptor Ligands Act As Tumor Suppressors in MLL-AF9 Mouse Leukemia

Orsola Di Martino, PhD, Margaret Y Ferris, MD PhD, Hadwiger Gayla, Haixia Niu, PhD, John S. Welch, MD PhD

Blood (2019) 134 (Supplement_1): 2677.

https://doi.org/10.1182/blood-2019-128869

Published: 2019

Journal Articles

Novel Therapy for Aggressive Cutaneous T-Cell Lymphoma Leading to Complete Clinical Remission before Allogenic Stem Cell Transplantation

Nicolas Gallastegui Crestani, MD, Mohammed E. Ibrahim, CRPH, BCOP, BCPS, BCACP, Ayman M. Mohamed, PharmD, Paolo Romanelli, MD, Amer Beitinjaneh, MD MPH, MSc, Jonathan H. Schatz, MD

Blood (2018) 132 (Supplement 1): 5354.

https://doi.org/10.1182/blood-2018-99-117079

Published: 2018

Journal Articles

Survival Benefit of Novel Drug Combinations Using Hypomethylating Agents for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Systemic Review

Pavan Tenneti, MD, Keri R Maher, DO, Mohamed Mokhtar Bakr, MD, Umar Zahid, MD MPH, Saad Ullah Malik, MD, Warda Faridi, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5182.

https://doi.org/10.1182/blood-2018-99-115810

Published: 2018

Journal Articles

Is Durability of Response Reported in Refractory CTCL: A Systematic Review

Mehul R Dalal, PhD, Stephen Mitchell, PhD, Conor McCloskey, PhD, Erin Zagadailov, PharmD, MS, Ashish Gautam, PhD

Blood (2017) 130 (Supplement 1): 5598.

https://doi.org/10.1182/blood.V130.Suppl_1.5598.5598

Published: 2017

Journal Articles

Combinatorial Use of Bexarotene Plus ATRA for the Treatment of Acute Myeloid Leukemia

Orsola Di Martino, PhD, Haixia Niu, PhD, John S. Welch, MD PhD

Blood (2017) 130 (Supplement 1): 1405.

https://doi.org/10.1182/blood.V130.Suppl_1.1405.1405

Published: 2017

Journal Articles

Reduction of Immunosuppression Does Not Significantly Impact Incidence of Renal Transplant Graft Rejection Following a Diagnosis of Post-Transplant Lymphoproliferative Disorder

Emily K Fay, MD, Abdolreza Haririan, MD MPH, Arnob Banerjee, MDPhD, Seung-Tae Lee, MD PhD, Jennie Y Law, MD

Blood (2017) 130 (Supplement 1): 5216.

https://doi.org/10.1182/blood.V130.Suppl_1.5216.5216

Published: 2017

Journal Articles

Inhibition of the Integrin αVβ3 Improves the Immune and Anti-Lymphoma Effects of Bexarotene in Cutaneous T-Cell Lymphoma (CTCL)

Maria Florencia Cayrol, Maria Mercedes Debernardi, Maria Victoria Revuelta, PhD, Alejandra Paulazo, Maria Nieves Calvo Vidal, PhD, Jude M Phillip, DPhil, Helena Sterle, Maria Celeste Diaz Flaque, Graciela Cremaschi, Leandro Cerchietti, MD

Blood (2017) 130 (Supplement 1): 732.

https://doi.org/10.1182/blood.V130.Suppl_1.732.732

Published: 2017

Journal Articles

Updated Analyses of the International, Open-Label, Randomized, Phase 3 Alcanza Study: Longer-Term Evidence for Superiority of Brentuximab Vedotin Versus Methotrexate or Bexarotene for CD30-Positive Cutaneous T-Cell Lymphoma (CTCL)

Blood (2017) 130 (Supplement 1): 1509.

https://doi.org/10.1182/blood.V130.Suppl_1.1509.1509

Published: 2017

Journal Articles

Long-Term Survival and Absence of Late Relapses in Patients Who Underwent Allogeneic Stem Cell Transplantation for Advanced Cutaneous T-Cell Lymphoma

Lori A Leslie, MD, Lori A. Leslie, MD, Tatyana A Feldman, MD, Alan P Skarbnik, MD, David H. Vesole, MD PhD, Scott D. Rowley, MD FACP, Andrew L. Pecora, MD, Andre Goy, MD, Michele L. Donato, MD

Blood (2016) 128 (22): 5843.

https://doi.org/10.1182/blood.V128.22.5843.5843

Published: 2016

Journal Articles

Brentuximab Vedotin Demonstrates Significantly Superior Clinical Outcomes in Patients with CD30-Expressing Cutaneous T Cell Lymphoma Versus Physician's Choice (Methotrexate or Bexarotene): The Phase 3 Alcanza Study

Youn H Kim, MD, Sean Whittaker, MB, ChB, FRCP, MD, Steven M Horwitz, MD, Madeleine Duvic, MD, Reinhard Dummer, MD, Julia J Scarisbrick, MBChB FRCP MD, Pietro Quaglino, MD, Pier Luigi Zinzani, MD PhD, Pascal Wolter, MD, Yinghui Wang, MS, Maria Corinna Palanca-Wessels, MD PhD, Erin Zagadailov, PharmD, MS, William L Trepicchio, PhD, Yi Liu, PhD, Meredith Little, MPH, H Miles Prince, MD

Blood (2016) 128 (22): 182.

https://doi.org/10.1182/blood.V128.22.182.182

Published: 2016

Journal Articles

How I treat mycosis fungoides and Sézary syndrome

Sean Whittaker, Richard Hoppe, H. Miles Prince

Blood (2016) 127 (25): 3142–3153.

https://doi.org/10.1182/blood-2015-12-611830

Published: 2016

Journal Articles

Results from a Phase 1/2, Open-Label, Dose-Finding Study of Pralatrexate and Oral Bexarotene in Patients with Relapsed/Refractory Cutaneous T-Cell Lymphoma

Madeleine Duvic, MD, Steven M Horwitz, MD, Youn H Kim, MD, Pier Luigi Zinzani, Gajanan Bhat, PhD, Pankaj Sharma, Sue Yancik

Blood (2015) 126 (23): 2677.

https://doi.org/10.1182/blood.V126.23.2677.2677

Published: 2015

Journal Articles

Extracorporeal Photopheresis for the Treatment of Mycosis Fungoides

Erden Atilla, MD, Pinar Ataca, MD, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Bengu Nisa Akay, MD, Hatice Sanli, MD, Pervin Topcuoglu, MD, Muhit Ozcan, MD, Gunhan Gurman, MD, Osman Ilhan

Blood (2015) 126 (23): 5062.

https://doi.org/10.1182/blood.V126.23.5062.5062

Published: 2015

Journal Articles

Clinical Features of Folliculotrophic Mycosis Fungoides

Wang Casey, MD, Rakhshandra Talpur, MD, Silvia Alberti-Violetti, MD, Iris Wieser, MD, Casey Tran, Madeleine Duvic, MD

Blood (2015) 126 (23): 1488.

https://doi.org/10.1182/blood.V126.23.1488.1488

Published: 2015

Journal Articles

Sézary Syndrome: Clinicopathological and Immunophenotypical Characteristics and Outcomes

Christa Roe, RN, BS, OCN, Jennifer Rock-Klotz, BA, Elyce Turba, RN, MSN, OCN, Christopher Rodriguez Salamanca, PA, Janice Bennett, MS, ARNP-C, Farrah Farquharson, PA, Sem Bastien, MS, ARNP-C, Barbara Williams, RN, BS, OCN, Rebecca Levy, MS, ARNP-C, Yibo Li, BS, Michael Montejo, MD, Ernesto Ayala, MD, Pedro Horna, MD, Lewis F Glass, MD, Rami S. Komrokji, MD, Lubomir Sokol, MD PhD

Blood (2015) 126 (23): 1546.

https://doi.org/10.1182/blood.V126.23.1546.1546

Published: 2015

Journal Articles

Natural Ligands for Rxra, but Not Rara, Are Observed in Mouse Bone Marrow Cells, and Are Augmented in Response to 5FU and GCSF

Haixa Niu, PhD, John Welch, MDPhD

Blood (2014) 124 (21): 4339.

https://doi.org/10.1182/blood.V124.21.4339.4339

Published: 2014

Journal Articles

Delineating the Nuclear Receptors Involved in Retinoid Responsiveness in CTCL Cells

Sebastian S. DeMarco, Lei Wang, JianMing Chen, Lance C. Bridges

Blood (2014) 124 (21): 5496.

https://doi.org/10.1182/blood.V124.21.5496.5496

Published: 2014

Journal Articles

Retinoids Selectively Induce Gut-Homing Properties in Cutaneous T Cell Lymphoma (CTCL) Cells

Lei Wang, Sebastian S. DeMarco, JianMing Chen, Lance C. Bridges

Blood (2014) 124 (21): 1766.

https://doi.org/10.1182/blood.V124.21.1766.1766

Published: 2014

Journal Articles

A Single Center Experience With Pralatrexate Alone Or In Combination With Bexarotene: Long Term Responses In Advanced Stage Relapsed/Refractory Cutaneous T-Cell Lymphoma

Rakhshandra Talpur, MD, Andrew Thompson, Pamela Gangar, Madeleine Duvic, MD

Blood (2013) 122 (21): 5113.

https://doi.org/10.1182/blood.V122.21.5113.5113

Published: 2013

NARROW

Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malignancy

Endogenous Retinoid X Receptor Ligands Act As Tumor Suppressors in MLL-AF9 Mouse Leukemia

Novel Therapy for Aggressive Cutaneous T-Cell Lymphoma Leading to Complete Clinical Remission before Allogenic Stem Cell Transplantation

Survival Benefit of Novel Drug Combinations Using Hypomethylating Agents for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Systemic Review

Is Durability of Response Reported in Refractory CTCL: A Systematic Review

Combinatorial Use of Bexarotene Plus ATRA for the Treatment of Acute Myeloid Leukemia

Reduction of Immunosuppression Does Not Significantly Impact Incidence of Renal Transplant Graft Rejection Following a Diagnosis of Post-Transplant Lymphoproliferative Disorder

Inhibition of the Integrin αVβ3 Improves the Immune and Anti-Lymphoma Effects of Bexarotene in Cutaneous T-Cell Lymphoma (CTCL)

Updated Analyses of the International, Open-Label, Randomized, Phase 3 Alcanza Study: Longer-Term Evidence for Superiority of Brentuximab Vedotin Versus Methotrexate or Bexarotene for CD30-Positive Cutaneous T-Cell Lymphoma (CTCL)

Long-Term Survival and Absence of Late Relapses in Patients Who Underwent Allogeneic Stem Cell Transplantation for Advanced Cutaneous T-Cell Lymphoma

Brentuximab Vedotin Demonstrates Significantly Superior Clinical Outcomes in Patients with CD30-Expressing Cutaneous T Cell Lymphoma Versus Physician's Choice (Methotrexate or Bexarotene): The Phase 3 Alcanza Study

How I treat mycosis fungoides and Sézary syndrome

Results from a Phase 1/2, Open-Label, Dose-Finding Study of Pralatrexate and Oral Bexarotene in Patients with Relapsed/Refractory Cutaneous T-Cell Lymphoma

Extracorporeal Photopheresis for the Treatment of Mycosis Fungoides

Clinical Features of Folliculotrophic Mycosis Fungoides

Sézary Syndrome: Clinicopathological and Immunophenotypical Characteristics and Outcomes

Natural Ligands for Rxra, but Not Rara, Are Observed in Mouse Bone Marrow Cells, and Are Augmented in Response to 5FU and GCSF

Delineating the Nuclear Receptors Involved in Retinoid Responsiveness in CTCL Cells

Retinoids Selectively Induce Gut-Homing Properties in Cutaneous T Cell Lymphoma (CTCL) Cells

A Single Center Experience With Pralatrexate Alone Or In Combination With Bexarotene: Long Term Responses In Advanced Stage Relapsed/Refractory Cutaneous T-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only